- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/52 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
Patent holdings for IPC class C07D 209/52
Total number of patents in this class: 531
10-year publication summary
|
31
|
28
|
34
|
27
|
23
|
17
|
21
|
35
|
38
|
19
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 70 |
13 |
| Novartis AG | 10686 |
11 |
| Pfizer Inc. | 3371 |
11 |
| Boehringer Ingelheim International GmbH | 4641 |
10 |
| Alkermes Pharma Ireland Limited | 267 |
9 |
| Cytokinetics, Inc. | 284 |
9 |
| Jiangsu Hengrui Medicine Co., Ltd. | 708 |
8 |
| Les Laboratoires Servier | 534 |
8 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 649 |
8 |
| Sumitomo Chemical Company, Limited | 9090 |
7 |
| Bristol-myers Squibb Company | 4845 |
6 |
| Amgen Inc. | 4129 |
6 |
| The General Hospital Corporation | 4784 |
6 |
| The Broad Institute, Inc. | 1856 |
6 |
| Schering Corporation | 425 |
6 |
| Vanderbilt University | 1922 |
6 |
| Hoffmann-La Roche Inc. | 3495 |
5 |
| Abbott Laboratories | 2396 |
5 |
| Massachusetts Institute of Technology | 10127 |
5 |
| DSM IP Assets B.V. | 5569 |
5 |
| Other owners | 381 |